tiprankstipranks
Cross Country Healthcare (CCRN)
NASDAQ:CCRN
US Market
CCRN
Cross Country Healthcare
RESEARCH TOOLSreports
Want to see CCRN full AI Analyst Report?

Cross Country Healthcare (CCRN) Ratios

267 Followers

Cross Country Healthcare Ratios

CCRN's free cash flow for Q1 2026 was $0.18. For the 2026 fiscal year, CCRN's free cash flow was decreased by $ and operating cash flow was
gt;-0.01. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 3.29 3.78 2.78 2.79 2.49
Quick Ratio
 3.29 3.78 2.78 2.79 2.45
Cash Ratio
 1.17 1.40 0.68 0.12 0.01
Solvency Ratio
 -0.60 -0.62 0.02 0.44 0.40
Operating Cash Flow Ratio
 0.52 0.62 1.00 1.67 0.49
Short-Term Operating Cash Flow Coverage
 48.60 41.49 0.00 0.00 0.00
Net Current Asset Value
$ 160.03M$ 167.46M$ 164.71M$ 209.23M$ 185.05M
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 <0.01 <0.01 0.17
Debt-to-Equity Ratio
 <0.01 <0.01 <0.01 0.01 0.35
Debt-to-Capital Ratio
 <0.01 <0.01 <0.01 0.01 0.26
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.25
Financial Leverage Ratio
 1.44 1.39 1.41 1.43 2.07
Debt Service Coverage Ratio
 -24.73 0.59 8.51 12.24 14.80
Interest Coverage Ratio
 -9.32 -1.56 -7.71 13.93 18.75
Debt to Market Cap
 <0.01 <0.01 0.00 0.00 0.15
Interest Debt Per Share
 0.14 0.14 0.18 0.38 4.65
Net Debt to EBITDA
 1.54 -7.98 -4.64 -0.09 0.55
Profitability Margins
Gross Profit Margin
19.84%18.66%20.41%22.30%22.28%
EBIT Margin
-8.27%-0.33%-0.05%5.50%9.54%
EBITDA Margin
-6.71%1.26%1.25%6.40%9.99%
Operating Profit Margin
-2.08%-0.33%-1.25%5.58%9.63%
Pretax Profit Margin
-8.62%-7.92%-1.22%5.09%9.03%
Net Profit Margin
-9.84%-9.00%-1.08%3.60%6.63%
Continuous Operations Profit Margin
-9.84%-9.00%-1.08%3.60%6.63%
Net Income Per EBT
114.23%113.58%88.77%70.59%73.48%
EBT Per EBIT
413.45%2412.19%97.23%91.29%93.78%
Return on Assets (ROA)
-21.87%-21.13%-2.47%10.69%19.62%
Return on Equity (ROE)
-27.10%-29.38%-3.47%15.34%40.68%
Return on Capital Employed (ROCE)
-5.79%-0.93%-3.60%21.24%39.91%
Return on Invested Capital (ROIC)
-5.78%-0.93%-3.18%14.92%29.15%
Return on Tangible Assets
-28.48%-26.53%-3.53%14.84%25.14%
Earnings Yield
-23.91%-36.13%-2.40%9.12%18.91%
Efficiency Ratios
Receivables Turnover
 5.44 6.29 5.53 5.20 4.25
Payables Turnover
 16.87 18.63 186.24 516.22 169.39
Inventory Turnover
 0.00 0.00 0.00 0.00 196.88
Fixed Asset Turnover
 34.44 35.17 42.91 67.46 122.33
Asset Turnover
 2.22 2.35 2.28 2.97 2.96
Working Capital Turnover Ratio
 4.73 4.90 5.59 6.02 7.87
Cash Conversion Cycle
 45.41 38.40 64.00 69.47 85.63
Days of Sales Outstanding
 67.05 57.99 65.96 70.18 85.93
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 1.85
Days of Payables Outstanding
 21.63 19.59 1.96 0.71 2.15
Operating Cycle
 67.05 57.99 65.96 70.18 87.78
Cash Flow Ratios
Operating Cash Flow Per Share
 1.50 1.49 3.60 7.07 3.62
Free Cash Flow Per Share
 1.26 1.24 3.34 6.67 3.38
CapEx Per Share
 0.25 0.25 0.26 0.40 0.24
Free Cash Flow to Operating Cash Flow
 0.84 0.83 0.93 0.94 0.93
Dividend Paid and CapEx Coverage Ratio
 6.12 5.91 13.78 17.78 15.26
Capital Expenditure Coverage Ratio
 6.12 5.91 13.78 17.78 15.26
Operating Cash Flow Coverage Ratio
 23.17 20.82 31.03 47.18 0.85
Operating Cash Flow to Sales Ratio
 0.05 0.05 0.09 0.12 0.05
Free Cash Flow Yield
9.34%15.27%18.38%29.46%12.74%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -4.18 -2.77 -41.64 10.96 5.29
Price-to-Sales (P/S) Ratio
 0.42 0.25 0.45 0.39 0.35
Price-to-Book (P/B) Ratio
 1.32 0.81 1.45 1.68 2.15
Price-to-Free Cash Flow (P/FCF) Ratio
 10.70 6.55 5.44 3.39 7.85
Price-to-Operating Cash Flow Ratio
 8.72 5.44 5.05 3.20 7.34
Price-to-Earnings Growth (PEG) Ratio
 0.03 >-0.01 0.34 -0.18 0.13
Price-to-Fair Value
 1.32 0.81 1.45 1.68 2.15
Enterprise Value Multiple
 -4.77 11.71 31.50 6.06 4.06
Enterprise Value
 320.34M 156.09M 528.40M 784.15M 1.14B
EV to EBITDA
 -4.77 11.71 31.50 6.06 4.06
EV to Sales
 0.32 0.15 0.39 0.39 0.41
EV to Free Cash Flow
 8.09 3.89 4.74 3.34 9.08
EV to Operating Cash Flow
 6.77 3.24 4.40 3.16 8.49
Tangible Book Value Per Share
 6.61 7.14 7.24 8.06 6.73
Shareholders’ Equity Per Share
 9.94 9.96 12.55 13.46 12.35
Tax and Other Ratios
Effective Tax Rate
 -0.14 -0.14 0.11 0.29 0.27
Revenue Per Share
 31.84 32.53 40.26 57.45 75.74
Net Income Per Share
 -3.13 -2.93 -0.44 2.07 5.02
Tax Burden
 1.14 1.14 0.89 0.71 0.73
Interest Burden
 1.04 24.12 22.62 0.93 0.95
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.15 0.19 0.19 0.15 0.00
Stock-Based Compensation to Revenue
 <0.01 0.00 <0.01 <0.01 <0.01
Income Quality
 -4.14 0.00 -8.25 3.42 0.72
Currency in USD